MLAB Mesa Laboratories Inc
- Stocks
- Technology
- NASDAQ: MLAB
Price (delayed)
$64.29
Market cap
$353.69M
P/E Ratio
N/A
Dividend/share
$0.64
EPS
-$0.12
Enterprise value
$513.59M
Mesa Labs is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries.
Highlights
Mesa Laboratories's net income has surged by 100% YoY and by 69% QoQ
The company's EPS has surged by 100% YoY and by 67% QoQ
The company's quick ratio has shrunk by 66% YoY and by 4.8% QoQ
Key stats
What are the main financial stats of MLAB
Market
Valuations
Earnings
Shares outstanding
5.5M
Market cap
$353.69M
Enterprise value
$513.59M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.03
Price to sales (P/S)
1.45
EV/EBIT
26.14
EV/EBITDA
11.5
EV/Sales
2.12
Revenue
$242.35M
Gross profit
$150.56M
Operating income
$17.14M
Net income
-$620,000
EBIT
$19.65M
EBITDA
$44.66M
Free cash flow
$33.9M
Per share
Balance sheet
Liquidity
EPS
-$0.12
EPS diluted
-$0.13
Free cash flow per share
$6.2
Book value per share
$31.62
Revenue per share
$44.35
TBVPS
$27.5
Total assets
$435.74M
Total liabilities
$263.25M
Debt
$181.18M
Equity
$172.5M
Working capital
-$51.24M
Debt to equity
1.05
Current ratio
0.66
Quick ratio
0.4
Net debt/EBITDA
3.58
Margins
Efficiency
Dividend
EBITDA margin
18.4%
Gross margin
62.1%
Net margin
-0.3%
Operating margin
7.1%
Return on assets
-0.1%
Return on equity
-0.4%
Return on invested capital
11.9%
Return on capital employed
6.9%
Return on sales
8.1%
Dividend yield
1%
DPS
$0.64
Payout ratio
N/A
MLAB stock price
How has the Mesa Laboratories stock price performed over time
Intraday
1.29%
1 week
-14.18%
1 month
-30.13%
1 year
-49.87%
YTD
-51.25%
QTD
-31.77%
Financial performance
How have Mesa Laboratories's revenue and profit performed over time
Revenue
$242.35M
Gross profit
$150.56M
Operating income
$17.14M
Net income
-$620,000
Gross margin
62.1%
Net margin
-0.3%
The operating margin has soared by 106% YoY and by 4.4% from the previous quarter
MLAB's operating income has soared by 106% YoY and by 4.9% from the previous quarter
The net margin has soared by 100% YoY and by 63% from the previous quarter
Mesa Laboratories's net income has surged by 100% YoY and by 69% QoQ
Price vs fundamentals
How does MLAB's price correlate with its fundamentals
Growth
What is Mesa Laboratories's growth rate over time
Valuation
What is Mesa Laboratories stock price valuation
P/E
N/A
P/B
2.03
P/S
1.45
EV/EBIT
26.14
EV/EBITDA
11.5
EV/Sales
2.12
The company's EPS has surged by 100% YoY and by 67% QoQ
MLAB's price to book (P/B) is 49% less than its last 4 quarters average of 4.0 and 35% less than its 5-year quarterly average of 3.1
MLAB's equity is up by 14% year-on-year and by 8% since the previous quarter
The P/S is 74% below the 5-year quarterly average of 5.5 and 46% below the last 4 quarters average of 2.7
MLAB's revenue is up by 8% year-on-year
Efficiency
How efficient is Mesa Laboratories business performance
Mesa Laboratories's return on invested capital has surged by 113% YoY and by 31% QoQ
The company's return on sales has surged by 107% YoY and by 9% QoQ
MLAB's return on equity has surged by 100% year-on-year and by 69% since the previous quarter
The return on assets has surged by 100% year-on-year and by 75% since the previous quarter
Dividends
What is MLAB's dividend history
DPS
$0.64
Dividend yield
1%
Payout ratio
N/A
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Mesa Laboratories financials performed over time
Mesa Laboratories's total assets is 66% more than its total liabilities
MLAB's current ratio has dropped by 66% year-on-year but it is up by 4.8% since the previous quarter
The company's quick ratio has shrunk by 66% YoY and by 4.8% QoQ
The debt is 5% more than the equity
MLAB's debt to equity is down by 26% YoY and by 5% QoQ
The debt has contracted by 15% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.